# Conventus Orthopaedics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/conventus-orthopaedics

- Industry: Medical Devices & Equipment
- Headquarters: Maple Grove, US
- Website: www.conventusortho.com
- Total disclosed funding: $24M
- Latest round: Series A (Dec 2, 2014)
- Investors on record: 7

## About

Conventus Orthopaedics Inc. is a medical technology company focused on developing innovative orthopedic solutions to simplify surgical procedures, enhancing safety and efficacy in patient care.Founded in 2008 by Michael Brenzel, Conventus Orthopaedics Inc. operates from Maple Grove, US. The company specializes in orthopedic devices and has successfully completed 8 deals, with its most recent being a USD 5 mn Venture Debt financing in December 2018, bringing the total amount raised to USD 20 mn.Conventus Orthopaedics develops advanced orthopedic solutions, including the Flex-Thread Distal Fibula and Ulna Intramedullary Nails, designed for minimally invasive treatment of fractures. Their product line also features the Constrictor Rope Syndesmosis Repair system, which offers enhanced fixation for ankle syndesmosis injuries. The company serves hospitals, surgical centers, and orthopedic surgeons mainly in the US and select international markets.Conventus Orthopaedics generates revenue primarily through B2B sales of its orthopedic solutions, including its flagship Flex-Thread Intramedullary Nails and Constrictor Rope Syndesmosis Repair system, offered as Ready-For-Surgery Solutions. These products are marketed under structured agreements with healthcare providers, reflecting the innovative design and efficiency benefits for surgical teams.Following the most recent deal in December 2018, Conventus Orthopaedics Inc. plans to leverage the USD 5 mn raised in Venture Debt financing to develop and launch upcoming orthopedic products and expand its market presence. Specific geographic regions for expansion are not disclosed, but the company aims to enhance its offerings by continuing to meet the needs of healthcare providers with innovative solutions.

## Funding rounds

- Series A, Dec 2, 2014, $24M — Bluestem Capital Company, Spray Venture Partners, BioStar Capital, SightLine Partners, Blue Sky, Deerfield Management, Ally Bridge Group

## Investors

- Bluestem Capital Company (https://capitalatlas.ai/funds/bluestem-capital-company) — Series A
- Spray Venture Partners (https://capitalatlas.ai/funds/spray-venture-partners) — Series A
- BioStar Capital (https://capitalatlas.ai/funds/biostar-capital) — Series A
- SightLine Partners — Series A
- Blue Sky (https://capitalatlas.ai/funds/blue-sky) — Series A
- Deerfield Management (https://capitalatlas.ai/funds/deerfield-management) — Series A
- Ally Bridge Group (https://capitalatlas.ai/funds/ally-bridge-group) — Series A